Trial intelligence / Profile preview

Levetiracetam versus placebo for prevention of early and late post-traumatic seizures after severe traumatic brain injury

2006-006518-13Phase 3Active

Sponsor
CHU Rennes
Start
Mar 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in post-traumatic epilepsy (PTE) comparing Levetiracetam with Placebo (2 arms). Primary endpoints: Prevention of early epileptic seizures and Prevention of late epileptic seizures. Started Mar 2007; status: active.

02

Drugs

levetiracetam
03

Conditions

post-traumatic epilepsy (PTE)

Beyond the preview

Go deeper on 2006-006518-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006518-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call